The role of molecular analysis in breast cancer
Abstract
Breast cancer is a heterogeneous disease, encompassing a wide variety of histological types and clinical behaviours. Current histopathological classification systems for breast cancer are based on descriptive entities that are of prognostic significance. Few predictive biomarkers are currently available.High throughput molecular technologies are reshaping our understanding of breast cancer and a molecular taxonomy that has stronger predictive power is slowly emerging. Novel therapeutic targets and prognostic/predictive gene signatures have been identified. This review will address the contribution of molecular methods to our understanding of breast cancer and its precursors, their use in breast cancer translational research and their impact on diagnostic breast cancer histopathology.Keywords
This publication has 160 references indexed in Scilit:
- Topoisomerase IIα gene status and prediction of pathological complete remission after anthracycline-based neoadjuvant chemotherapy in endocrine non-responsive Her2/neu-positive breast cancerThe Breast, 2008
- How basal are triple‐negative breast cancers?International Journal of Cancer, 2008
- Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patientsBreast Cancer Research and Treatment, 2007
- Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysisBreast Cancer Research and Treatment, 2007
- A mouse model of basal‐like breast carcinoma with metaplastic elementsThe Journal of Pathology, 2007
- Prognostic markers in triple‐negative breast cancerCancer, 2006
- Genomic and transcriptional aberrations linked to breast cancer pathophysiologiesCancer Cell, 2006
- Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiationThe Journal of Pathology, 2006
- High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analysesInternational Journal of Cancer, 2005
- Expression of luminal and basal cytokeratins in human breast carcinomaThe Journal of Pathology, 2004